Navigating Cannabis Insurance with Jay Virdi

Navigating Cannabis Insurance with Jay Virdi

Author: Cannabis Radio July 10, 2024 Duration: 40:36

We welcome Jay Virdi, Chief Sales Officer for Specialty Practices at HUB International, to discuss the evolving landscape of the cannabis industry and the complex world of cannabis insurance.  

Jay discusses the intricacies of interstate commerce limitations and the potential scenarios if neighboring states collaborate on cannabis trade before full federal legalization. They delve into the recent DEA rescheduling of cannabis to Schedule III, its impact on the industry, and the possible effects on insurance premiums and coverage.

The conversation also covers the substantial growth of HUB International's cannabis practice group, now serving over 1,000 clients with a dedicated team of more than 300 members. Jay shares insights into alternative risk financing strategies, such as parametric derivatives and captives, and the proprietary HUB Cannabis Benefits Captive designed to cover employees.

Additionally, we discuss the increasing number of insurance carriers entering the cannabis market and the ongoing challenges cannabis businesses face in securing comprehensive coverage. They highlight the importance of specialized knowledge in underwriting and risk management to address the unique needs of cannabis-related businesses.

Listeners will gain valuable perspectives on how HUB International leverages its expertise in emerging markets, including psychedelics and cryptocurrencies, to support the cannabis industry. Jay also emphasizes the company's commitment to human-centric programs and the integration of artificial intelligence to enhance service delivery.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 100

Blunt Business
Podcast Episodes
A Psychedelic and Cannabis Research Revolution On the Horizon? [not-audio_url] [/not-audio_url]

Duration: 29:28
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental h…
4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge? [not-audio_url] [/not-audio_url]

Duration: 24:45
As the legal landscape evolves, the traditional 4/20 retail boom is showing signs of cooling, with some markets seeing higher sales during the surrounding week than on the holiday itself due to aggressive discounting and…
Inside New York’s Five-Year Cannabis Chronicle [not-audio_url] [/not-audio_url]

Duration: 29:51
In this episode of The Blunt Business, the discussion dives deep into the complex landscape of the New York cannabis market as it hits its five-year legalization anniversary. While Governor Kathy Hochul lauds the state’s…
The Cannabis Business CLIMB or Cannabis for Healthy Livers [not-audio_url] [/not-audio_url]

Duration: 17:24
Blunt Business dives into the shifting landscape of American cannabis, from the halls of Congress to the microscopic world of medical research. We break down the newly proposed CLIMB Act, a bipartisan bill aimed at final…